Lv1
92 积分 2023-04-21 加入
DGKH-mediated phosphatidic acid oncometabolism as a driver of self-renewal and therapy resistance in hepatocellular carcinoma
1个月前
已完结
The KRASG12C Inhibitor, MRTX849, Provides Insight Toward Therapeutic Susceptibility of KRAS Mutant Cancers in Mouse Models and Patients
1个月前
已完结
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC
1个月前
已完结
Data from Impact of Co-mutations and Transcriptional Signatures in Non–Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 Trial
1个月前
已关闭
CRISPR screening identifies mechanisms of resistance to KRASG12C and SHP2 inhibitor combinations in non-small cell lung cancer
1个月前
已完结
TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors
1个月前
已完结
All Roads Lead to Rome: YAP/TAZ Activity Influences Efficacy of KRASG12C Inhibitors
1个月前
已完结
Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy
1个月前
已完结
Human-correlated genetic models identify precision therapy for liver cancer
2个月前
已完结
Molecular Basis of Colorectal Cancer
3个月前
已关闭
皖公网安备34019202002308
